DXCM - DexCom Inc logo

DXCM

DexCom Inc

Net income grew 100% of yearsRevenue grew 100% of years1Y
Compare DXCM Hold

DexCom, Inc. designs and develops continuous glucose monitoring systems for diabetes management, including the Dexcom G7, G6, and Stelo biosensor. Its products help patients monitor glucose levels and are marketed to healthcare professionals and diabetes educators.

โš•๏ธ Healthcare NASDAQ Listed 2005 $ USD
$1,000 invested 1 year ago โ†’$1,292today

Score Overview

1 Year
Score
Net Growth19.54%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth6.59%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score9.4
Net Growth360.90%
Net TrendEvery year
Net Income Consistencyโ€”
Rev Growth102.95%
Rev TrendEvery year
Revenue Consistencyโ€”
10 Years
Score
Net Growth17x
Net Trend80%
Net Income Consistency
Rev Growth8x
Rev TrendEvery year
Revenue Consistency
20 Years
Score7.1
Net Growth23x
Net Trend65%
Net Income Consistency
Rev Growth2290x
Rev TrendEvery year
Revenue Consistency
All Time
Scoreโ€”
Net Growth34x
Net Trend62%
Net Income Consistency
Rev Growthโ€”
Rev TrendEvery year
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where DexCom Inc has ranked, year by year

Measure
Fundamentals Window

Showing 10 years ranking history by HDB Score.

Has not reached the top 50 on HDB Score in any year we have ranked.

  • DXCM

2017: 53.7% ยท 2021: 29.3% ยท free through 2021 ยท longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-28
$ 86.68โ€”
1 Year2025-09-26
$ 67.1029.18%
5 Years2021-09-28
$ 134.24-35.43%
10 Years2016-09-28
$ 22.43286.36%
20 Years2006-09-28
$ 2.6932x
All Time2005-04-14
$ 2.9429x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 4.96B$ 999M$ 1.94B
2025$ 4.66B$ 836M$ 1.99B
2024$ 4.03B$ 576M$ 2.57B
2023$ 3.62B$ 541M$ 2.72B
2022$ 2.90B$ 341M$ 2.45B
2021$ 2.44B$ 216M$ 2.73B
2020$ 1.92B$ 493M$ 2.70B
2019$ 1.47B$ 101M$ 1.53B
2018$ 1.03B-$ 127M$ 1.38B
2017$ 718M-$ 50M$ 548M
2016$ 573M-$ 65M$ 123M
2015$ 402M-$ 57M$ 115M
2014$ 259M-$ 22M$ 83M
2013$ 160M-$ 29M$ 54M
2012$ 99M-$ 54M$ 48M
2011$ 76M-$ 44M$ 81M
2010$ 48M-$ 55M$ 47M
2009$ 29M-$ 53M$ 28M
2008$ 9M-$ 55M$ 27M
2007$ 4M-$ 45M$ 64M
2006$ 2M-$ 46M$ 54M
IPO2005-$ 30M$ 50M
DXCM - DexCom Inc logo

DexCom Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 1.92B to $ 4.66B and net income grew from $ 493M to $ 836M. Revenue increased in every one of those 5 years; net income in every one.

Between 2015 and 2025, revenue grew from $ 402M to $ 4.66B and net income went from -$ 57M to $ 836M. Revenue increased in every one of those 10 years; net income in 8.

DexCom Inc currently holds a 20-year HDB Score of 7.1 out of 10. How the HDB Score is calculated.

Membership

Continue DXCMโ€™s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,816 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies